Scientia Advisors in the News

---

Publications

---

Press Releases

---

Events

---

Luminary Insights

---

Media Contact

---

Scientia Advisors in the News

Harry Glorikian Comments on the Cambridge Area's Attractiveness to Pharmaceutical Companies in a Boston Globe Article on Novartis doubles plan for Cambridge

Casey Ross and Robert Weisman
October 27, 2010

In this article on Novartis' plan to double the size of a planned office and lab complex in Cambridge, the authors quote Harry Glorikian commenting on why this particular Boston area has become a magnet for international pharmaceutical companies looking for access to cutting-edge drug research at MIT and Harvard University.

Read the full article at: The Boston Globe